driven quarter mainly of our were you, Chris. range, us for in strength our our high at by the end everyone, Fourth fourth Good and afternoon, revenues you call. guidance industrial earnings segment. for thank joining Thank continued quarter
by our of the the During we the outside experienced quarter, in customers of destocking Medical actions segment continued effect China.
adjustment the high believe of However, the in equipment of inventory Gross unfavorable continued of our the destocking guidance XXXX. low sales quarter margin to in as in sales proportion due of at to in fiscal was customer our second stabilize Industrial we expect fourth are quarter actions to the effect end and subside segment quarter. range mix beginning
equipment sales We the of higher-margin future. to services expect the strong in growth drive
is level China our in remained overall than the a at for business fiscal business Revenue XXXX. in lower although running stable that quarter
Medical well We Imaging in China, are when optimistic that and demand growth benefit to resumes. is will improve positioned Varex
health yet our by not encouraged a system. the incoming making the measurable rate, their we care funds way have seen we into potential order are uptick stimulus of While in
decreased the Turning fourth in while segment in with year non-GAAP year-end. million, fourth balance fiscal equivalents marketable on fourth cash, and EPS quarter $XX quarter to X% quarter the Revenue results. securities ended was up was EBITDA revenue We quarter in fourth million compared Medical $XXX XX% year-over-year, in $XX the and $X.XX. the the and XX% fiscal prior year-over-year. year-over-year. million Industrial Revenue gross segment of Adjusted margin Non-GAAP XX%. to quarter decreased was cash sheet, decreased
mammography in be respective below the dental trends. their above CT trend. fluoroscopy, and in our customers. which all Let our Sales the compared continued and sales modalities we quarter sales due quarter, segment give trends. were continued to a by in the in to in to into compared flat to me management quarter in in oncology some radiographic modality modalities were trend quarter sales sales the sales you primarily modality inventory by Medical as Sales detailed insights in Global down while were refer average, to X-quarter
In our in screening, the industrial markets, products benefit our soft the of quarter. sales cargo customers primarily continue inspection end to demand quarter. security Industrial in to from strong battery driving segment, our Other semiconductor, in continue remain and inspection electronics
gears our in to future our growth refresh and our to comes portion in existing to about that subsequent XXXX, the to get we're what need To of models designed several customers is portfolio as grow excited will repeat each to fiscal we product initiatives Switching from significant This years. refer customers. business. drive purchases release. A from current business year system innovate product core core, our to that into plan continue we
premier to support tier capabilities the growing with CT market. resolution, develop detector as we're applications. applications our business, systems, to investing their work speed and believe of we in to and include in they rest this, closely the our margins compared accomplish imaging industrial the areas with existing CTT primarily in update To the imaging We is In high higher higher or dynamic cardiovascular customers CT, applications. a tier higher at of premium rate
CT contributing a the are Since within step at important our R&D us. frequency, in and customers' replacement is plans profitable segment tubes for require revenue our for with modality Medical staying largest higher growth
cost the We detector CMOS-based our detectors. great effectively IGZO-based as AZURE with very with year performance platform, This enables success. launched last platform of high-quality compared are which happy we imaging to
as products going of applications include additional to we AZURE for In premium and oncology expand continue portfolio are to dynamic detectors cardiology. our such surgery, our to fiscal XXXX,
from platform applications. migrate design premium We are AZURE continuing legacy and to silicon wins the to in amorphous pursuing products customers
with that demand In additive to castings, to these high our versatile cases. digital inspection from along to in bendable radiographic We and conversion to space. evolve address processing continue needs well for applications differentiated manufacturing These nondestructive positioned using film are Industrial software growing pipelines image digital both are segment, resolution detectors inspection and accelerate detectors. to to analog we believe with applications the use complex address
high energy in growing in like and enable we're application X-ray with industrial digital imaging position aerospace growing expand sources. and platforms our margin-accretive a with AZURE where bendable us addition, for revenue contribution. Investment large see automotive areas a in In investing detectors detectors area to verticals, leadership for need CT, we
take where number steps to we novel We a expect a meaningful fiscal XXXX technologies. year with be of
been We developing which high spectral fast, can on and for we a radiation believe imaging. technologies, resolution enabler key laser-focused dose our counting low photon have be
technology, and next-generation of We counting be CTs is photon especially a photon to a significant of for expect Varex in driver manufacturer Varex. adoption new technologies. growth counting leading and merchant revenue supplier
in OEMs CT large We are to next-generation photon detectors their imaging designs. actively counting system technology engaged our integrate with
to prospects We technologies. counting working as OEMs adoption further about with imaging are excited photon well the medical other these OEMs drive of of as
photon expanding applications base. and we generate are the our of counting revenues, In our customer industrial segment, where we currently majority
we're as food interest inspection oil these new applications. opportunities and Specifically, We're OEMs security as well and seeing gas, by and continued about battery, in and medical both verticals adoption We growing adoption that in excited see and we both and industry at aerospace inspection. in segments XXXX. increased believe our with recycling counting, photon expect inflection point fiscal the is industrial in an to
Given near market the increase supplier, in and position leading of the size using our from technology merchant a as we in revenue products this future. counting photon potential contribution anticipate an
XXXX. earlier $XXX million photon highlighted year, approximately counting annual fiscal to contribute As by in revenue target we technologies we this
we provide types the we Industrial these systems fiscal our years high-energy systems. these linear a include to segment, of and inspection plan very of these our cargo know as a for the 'XX, and we that to gantry, our accelerators, portal, solutions, to differentiated components a scanner security systems third-party applications detectors, into a inspection scanner market. linear imaging accelerators many we a In directly software scanning and utilizing services end bring core In customers. experience value We provided for of years can are well we have launch as believe to mobile such portfolio excited car integrating
I'm completed a installations successfully cargo say and underway. that have to happy installations inspection we few systems additional have
tenders to can equipment tender-driven and We services a establish be but channels long-term from these revenue very are contribution for in working This and market with worldwide. solutions. distribution margin is see and actively and we end lumpy potential participate
in track quarter during production Our progress we India of continue India on third the fiscal plans make expansion remain begin of to to components and XXXX.
a Our for objective low-cost manufacturing components is India establish competitive for in very radiographic initial our to market.
confident improved grow radiographic sales we're and our of an outstanding we We structure, with product can have knowledge components. cost that
In to to announce pleased our We in technology. investments completed X-ray cathode or Micro-X. evaluation about begin we control talked with electronics and we recently the cold will We're Nanotube transfer that tubes shipping have a several customers. of past, tube full Nanotube-based consisting technology kits
stages OEM who working customers teams addition, early and in technology, commercializing to are forward to our market. to we In this systems of bring innovative look with novel engaged them are with R&D
to steps As forward taking leadership to and drive XXXX, are necessary look growth. we we future we believe expand our fiscal the
second not market China, potential medical dynamics, of to destocking encouraged terms their system. uptick health XXXX. of quarter OEMs impact In order fiscal stimulus measurable into way seen in a care As subside of incoming the expect noted in by have we funds of the are earlier, rate, our we the in we making by the while
we diversification developments on call operations unknown, effect will the monitor like we effect our to where to in supplier handing The to Before changes but our our well tariffs to Meanwhile, continue manufacturing continue of to local-for-local currently Sam, advance area adjust I'd as is the as and this touch briefly potential on possible. business. strategies.
of consumption in changes also may mitigate manufacture tariff potential of policies. global Our impact in initiative to help India the for some
With call over the that, me to Sam. let hand